Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuromuscular Blockade Reversal Agent”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Post-approval studies (Phase 4)Study completedNCT04332627
What this trial is testing

Comparison of QoR-15 in Laparoscopic Cholecystectomy: Sugammadex vs. Neostigmine

Who this might be right for
Neuromuscular Blockade Reversal AgentSugammadexNeostigmine+2 more
Seoul National University Bundang Hospital 77
Post-approval studies (Phase 4)Not Yet RecruitingNCT07477132
What this trial is testing

A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 and 24 Months Old

Who this might be right for
Curarization, Postoperative Residual
University Hospital, Caen 99
Post-approval studies (Phase 4)Study completedNCT01785758
What this trial is testing

Efficacy and Safety of Sugammadex in Renal Diseased Patients

Who this might be right for
Kidney Failure, ChronicNeuromuscular Blockade
Federal University of São Paulo 40
Post-approval studies (Phase 4)Active Not RecruitingNCT07044180
What this trial is testing

Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Propofol Anesthesia

Who this might be right for
Neuromuscular Blocking AgentsResidual Neuromuscular BlockReversal of Neuromuscular Blockade
Tamas Vegh, MD 80
Not applicableStudy completedNCT06962007
What this trial is testing

Sugammadex-Induced Clenching During Neuromuscular Blockade Reversal

Who this might be right for
Neuromuscular Blockade Reversal AgentPerioperative ComplicationsAnesthesia, General+3 more
Wonkwang University Hospital 240
Large-scale testing (Phase 3)Study completedNCT00473694
What this trial is testing

Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025)

Who this might be right for
Anesthesia, General
Merck Sharp & Dohme LLC 182
Not applicableActive Not RecruitingNCT06948409
What this trial is testing

NMBA Reversal and Postoperative Urinary Retention

Who this might be right for
Neuromuscular Blocking AgentsUrinary Retention After ProcedureUrinary Retention Postoperative+8 more
Beth Israel Deaconess Medical Center 70,000
Not applicableStudy completedNCT04873531
What this trial is testing

Feasibility of Neostigmine for Intraoperative Neuromonitoring in Thyroid Surgery

Who this might be right for
Thyroid DiseasesSurgical InjuryNerve Monitoring
Seoul National University Hospital 44
Post-approval studies (Phase 4)Study completedNCT02568345
What this trial is testing

Sugammadex ED90 Dose in the Obese Patients

Who this might be right for
Incomplete Reversal of Neuromuscular Block
Faculdade de Ciências Médicas da Santa Casa de São Paulo 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07595393
What this trial is testing

A Dose-Finding Study of Amogammadex Sodium for Reversing Vecuronium and Rocuronium-Induced Neuromuscular Blockade

Who this might be right for
Reversing Vecuronium-Induced Neuromuscular Blockade in Patients Undergoing General Anesthesia SurgeryReversing Rocuronium-Induced Neuromuscular Blockade in Patients Undergoing General Anesthesia Surgery
Amckaus PTY LTD. 64
Post-approval studies (Phase 4)Not Yet RecruitingNCT07044193
What this trial is testing

Reversal of Pipecuronium-induced Neuromuscular Blockade With Sugammadex During Sevoflurane Anesthesia

Who this might be right for
Neuromuscular Blocking AgentsResidual Neuromuscular BlockReversal of Neuromuscular Blockade
Tamas Vegh, MD 80
Post-approval studies (Phase 4)Study completedNCT02455921
What this trial is testing

Neuromuscular Blockade Reversal Agent Effect on Postoperative Cognitive Function and Behaviour in Children

Who this might be right for
Anesthesia; Functional
Attikon Hospital 200